| scholarly article | Q13442814 |
| P50 | author | Nilanjan Chatterjee | Q21526241 |
| Montserrat García-Closas | Q28356305 | ||
| P2093 | author name string | Necdet Burak Gunsoy | |
| P2860 | cites work | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | Q36897003 |
| Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer | Q36944260 | ||
| Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model | Q37172219 | ||
| Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status | Q37223335 | ||
| Genetic susceptibility to breast cancer | Q41130542 | ||
| Family history and the risk of breast cancer: a systematic review and meta-analysis | Q41495151 | ||
| Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care | Q43074048 | ||
| Sick individuals and sick populations | Q43440816 | ||
| Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. | Q50511174 | ||
| Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? | Q51656703 | ||
| Effects of mammographic density and benign breast disease on breast cancer risk (United States). | Q53400677 | ||
| Public health implications from COGS and potential for risk stratification and screening | Q86499074 | ||
| Genome-wide association studies identify four ER negative-specific breast cancer risk loci | Q24622610 | ||
| Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis | Q24628928 | ||
| Benign breast disease and the risk of breast cancer | Q28262894 | ||
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
| Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data | Q30575708 | ||
| Active smoking and breast cancer risk: original cohort data and meta-analysis | Q30596236 | ||
| Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data | Q30620889 | ||
| Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease | Q30747351 | ||
| Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study | Q33935171 | ||
| Performance of common genetic variants in breast-cancer risk models | Q34064069 | ||
| Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study | Q34613673 | ||
| Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium | Q35166701 | ||
| Population-based screening in the era of genomics | Q36233914 | ||
| Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies | Q36368636 | ||
| Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement | Q36393193 | ||
| Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis | Q36507079 | ||
| Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors | Q36720821 | ||
| Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers | Q36742577 | ||
| Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk | Q36858843 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| prevention | Q1717246 | ||
| P577 | publication date | 2014-11-12 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer | |
| P478 | volume | 106 |
| Q92199197 | A systematic review and quality assessment of individualised breast cancer risk prediction models |
| Q57748350 | Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study |
| Q93384078 | Aged Garlic and Cancer: A Systematic Review |
| Q56893420 | Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies |
| Q91045517 | BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors |
| Q39734134 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States |
| Q87909686 | Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening |
| Q64074174 | Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model |
| Q91211233 | Cancer genetics, precision prevention and a call to action |
| Q26995183 | Cancer prevention as part of precision medicine: 'plenty to be done' |
| Q90300115 | Choosing Breast Cancer Risk Models: Importance of Independent Validation |
| Q59238197 | Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation |
| Q92528444 | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification |
| Q31064480 | Constructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk |
| Q57177092 | Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model |
| Q47251942 | Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases |
| Q30251440 | Developing and evaluating polygenic risk prediction models for stratified disease prevention |
| Q28084601 | Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling? |
| Q52809057 | Epigenome-based cancer risk prediction: rationale, opportunities and challenges. |
| Q90929499 | Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits |
| Q98184153 | European polygenic risk score for prediction of breast cancer shows similar performance in Asian women |
| Q38659935 | Genetic screening for gynecological cancer: where are we heading? |
| Q91525724 | Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico |
| Q40310422 | Implications of polygenic risk for personalised colorectal cancer screening |
| Q37360550 | Integrating precision cancer medicine into healthcare-policy, practice, and research challenges |
| Q36763159 | Integration of genetic and epigenetic markers for risk stratification: opportunities and challenges. |
| Q89866318 | Interactions between a Polygenic Risk Score and Non-genetic Risk Factors in Young-Onset Breast Cancer |
| Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q37463923 | Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors. |
| Q92510711 | Performance of BCRAT in high-risk patients with breast cancer |
| Q96577047 | Personalized early detection and prevention of breast cancer: ENVISION consensus statement |
| Q47692611 | Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q37513339 | Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps |
| Q38820915 | Precisely Where Are We Going? Charting the New Terrain of Precision Prevention. |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q47409320 | Predictive accuracy of combined genetic and environmental risk scores |
| Q36770292 | Re: Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer |
| Q37524981 | Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies |
| Q30251624 | Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know? |
| Q26991921 | Risk determination and prevention of breast cancer |
| Q54950358 | Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. |
| Q61755960 | The Genetic Sphygmomanometer: an argument for routine genome-wide genotyping in the population and a new view on its use to inform clinical practice |
| Q38703578 | The selective estrogen receptor modulators in breast cancer prevention |
| Q64240122 | Towards a more precise and individualized assessment of breast cancer risk |
| Q36294980 | Twenty-five years of breast cancer risk models and their applications |
| Q59335358 | Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer |
| Q36255311 | Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention |
| Q33752543 | What Does "Precision Medicine" Have to Say About Prevention? |
Search more.